Associate Professor of Biology Martin Wu has been awarded funding from the Global Infectious Diseases Institute for his research on a point-of-care diagnostic test for COVID-19. As described in today's issue of UVAToday, "Current nucleic acid-based tests for active COVID-19 infection require expensive equipment suited to large, centralized diagnostic laboratories. Using the rapid-response funding, biology professor Martin Wu and his team will develop a simple, cheap and quick test based on a PCR “dipstick” technology. If successful, this new test can be deployed widely in communities for rapid, decentralized point-of-care diagnosis and epidemiological surveillance." Congratulations to Martin and his team! To learn more about the funding initiative, please click here to read the full article.